Verismo Therapeutics' Initial Clinical Data from STAR-101 Phase 1 Trial of SynKIR™-110 KIR-CAR Presented at AACR 2026 Plenary Session

Early clinical data show a favorable safety profile and dose-dependent efficacy signals across initial dose level cohorts 1 - 3 in advanced solid tumors for potential first of its kind multi-chain KIR-CAR living medicine Preliminary data suggest on-tumor target biologic activity with...